Within its Open Call managed by MIH, NextGenMicrofluidics offers funded services to SMEs and LEs who are looking for support to accelerate their innovation and production cycles enabled through foil based microfluidic chips (lab-on-a-foil systems) or microfluidic composite devices with foil based components. For more information on the Open Call, visit our page here.
LEARN MORE ABOUT OUR
Accepted Projects
The following projects have received funding through the Open Call:
Sperm selection chip to increase chances of in-vitro fertilization
Applicant: Dr. Nerea Subiran, MEPROlife s.l.
Total Budget: 133,324€
Funding Rate: 85% (113,521€)
Duration: 10 months
NGM Partners Involved: Biomedical Research Foundation of the Academy of Athens, Fundacion Tecnalia Research & Innovation, Micronit b.v., Inmold A/S
Application: IVF for infertility treatment
On-site Mycotoxin Detection (Aflatoxin M1, B1) in Food/ Feed
Applicant: Dr. Patrizia Melpignano, Or-El d.o.o.
Total Budget: 64,100€
Funding Rate: 92% (59,000€)
Duration: 8 months
NGM Partners Involved: BiFlow Systems GmbH, Joanneum Research Forschungsgesellschaft mbH, Ibidi GmbH
Application: Food safety
Point-of-care whole blood analyzer
Applicant: EXIAS Medical GmbH
Total Budget: 126,294 €
Funding Rate: 83% (104,720 €)
Duration: 6 months
NGM Partners Involved: Biomedical Research Foundation of the Academy of Athens, bionic surface technologies GmbH, Joanneum Research Forschungsgesellschaft mbH, Fundacion Tecnalia Research & Innovation
Application: Blood analysis
Point-of-care test to improve diagnosis and disease monitoring of Chronic Kidney Diseases
Applicant: Hycult Biotech
Total Budget: 127,307 €
Funding Rate: 82.8% (105,480 €)
Duration: 12 months
NGM Partners Involved: GENSPEED Biotech GmbH, JOANNEUM RESEARCH Forschungsgesellschaft mbH, Inmold A/S, Micronit b.v., micro resist technology GmbH
Application: Rapid diagnosis, disease monitoring and evaluating treatment efficacy in patients suffering from Chronic Kidney Disease
Point-of-Care test towards multiplex detection of inflammatory biomarkers for critical care patient triaging
Applicant: ViroGates A/S
Total Budget: 199,888 €
Funding Rate: 63.05% (126,036€)
Duration: 12 months
NGM Partners Involved: GENSPEED Biotech GmbH, JOANNEUM RESEARCH Forschungsgesellschaft mbH, Inmold A/S, Micronit b.v., micro resist technology GmbH, Biomedical Research Foundation of the Academy of Athens
Application: Rapidly quantifying inflammation and immune activation levels of hospital patients